市場調査レポート
商品コード
1298856

持続グルコースモニタリングシステム市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測

Continuous Glucose Monitoring Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 144 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
持続グルコースモニタリングシステム市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測
出版日: 2023年06月14日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の持続グルコースモニタリングシステム市場規模は2022年に61億米ドルに達しました。今後、IMARC Groupは、市場は2023年から2028年の間に5.7%の成長率(CAGR)を示し、2028年までに86億米ドルに達すると予測しています。

持続グルコースモニタリングシステム(CGMS)は、血糖値を自動的に追跡する技術的に高度な装置です。CGMSは、経皮または皮下経路で機能する送信機一体型センサーで構成され、間質液中のグルコース濃度を継続的に測定します。トランスミッターはその後、衣服にクリップで留められるワイヤレスモニターに情報を送信します。持続グルコースモニタリングシステムは、糖尿病の完全なプロファイルを提供し、血糖値の高低を警告し、パターンを検出し、身体活動、薬の選択、食事の量、ストレスに関する患者の洞察を深めるのに役立つ。従来のグルコースモニタリングデバイスと比較して、CGMSは皮膚の上に置くことができるため刺す必要がなく、迅速かつ痛みのない方法でリアルタイムの情報を提供するのに役立ちます。

持続グルコースモニタリングシステム市場の動向:

糖尿病を発症しやすい老年人口が世界中で増加していることが、市場に明るい展望をもたらしています。CGMSは一般的に体内のグルコースとインスリンのレベルを測定するために使用され、危険なレベルまで低下したり上昇したりするとアラームが鳴ります。これに伴い、低血糖や高血糖の状況をリアルタイムで特定するために製品が広く利用されていることが、市場の成長を後押ししています。さらに、糖尿病患者の糖化ヘモグロビン(Hb1ac)の検出を支援するCGMSの大幅な改良と新技術の進歩が、市場の成長を大幅に後押ししています。さらに、人工膵臓装置システムとCGMS技術の統合により、患者の血糖値を管理するためにインスリンを汲み上げ、最適な投与量を投与することが、市場成長にプラスの影響を与えています。これとは別に、便利な代替手段としての非侵襲性CGMSデバイスのイントロダクション、広範な研究開発(R&D)活動、および低侵襲性または低侵襲性の診断ツールに対する需要の高まりが、市場のさらなる成長を促進すると予測されています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 持続グルコースモニタリングシステムの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:コンポーネント別

  • センサー
    • 市場動向
    • 市場予測
  • トランスミッターとレシーバー
    • 市場動向
    • 市場予測
  • 一体型インスリンポンプ
    • 市場動向
    • 市場予測

第7章 市場内訳:人口動態別

  • 小児人口(14歳以下)
    • 市場動向
    • 市場予測
  • 成人人口(14歳以上)
    • 市場動向
    • 市場予測

第8章 市場内訳:エンドユーザー別

  • 診療所・診断センター
    • 市場動向
    • 市場予測
  • ICU市場
    • 市場動向
    • 市場予測
  • 在宅ヘルスケア
    • 市場動向
    • 市場予測

第9章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要プレーヤー
  • 主要プレーヤーのプロファイル
    • A. Menarini Diagnostics S.r.l.
    • Abbott Laboratories
    • DexCom Inc.
    • F. Hoffmann-La Roche AG
    • Glysens Incorporated
    • LifeScan Inc.(Johnson & Johnson)
    • Medtronic PLC
    • Medtrum Technologies Inc.
    • Nemaura Medical Inc.
    • Novo Nordisk A/S
    • Senseonics Holdings Inc.
    • Waveform Technologies Inc.
図表

List of Figures

  • Figure 1: Global: Continuous Glucose Monitoring Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Continuous Glucose Monitoring Systems Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Continuous Glucose Monitoring Systems Market: Breakup by Component (in %), 2022
  • Figure 5: Global: Continuous Glucose Monitoring Systems Market: Breakup by Demographics (in %), 2022
  • Figure 6: Global: Continuous Glucose Monitoring Systems Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Continuous Glucose Monitoring Systems Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Continuous Glucose Monitoring Systems (Sensors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Continuous Glucose Monitoring Systems (Sensors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Continuous Glucose Monitoring Systems (Child Population (≤14 years)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Continuous Glucose Monitoring Systems (Child Population (≤14 years)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Continuous Glucose Monitoring Systems (ICUs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Continuous Glucose Monitoring Systems (ICUs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: North America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: North America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: United States: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: United States: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Canada: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Canada: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Asia-Pacific: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Asia-Pacific: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: China: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: China: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Japan: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Japan: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: India: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: India: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: South Korea: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: South Korea: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Australia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Australia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Indonesia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Indonesia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Europe: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Europe: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Germany: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Germany: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: France: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: France: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: United Kingdom: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: United Kingdom: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Italy: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Italy: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Spain: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Spain: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Russia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Russia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Latin America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Latin America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Brazil: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Brazil: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Mexico: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Mexico: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Breakup by Country (in %), 2022
  • Figure 72: Middle East and Africa: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Global: Continuous Glucose Monitoring Systems Industry: SWOT Analysis
  • Figure 74: Global: Continuous Glucose Monitoring Systems Industry: Value Chain Analysis
  • Figure 75: Global: Continuous Glucose Monitoring Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Continuous Glucose Monitoring Systems Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Component (in Million US$), 2023-2028
  • Table 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Demographics (in Million US$), 2023-2028
  • Table 4: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Continuous Glucose Monitoring Systems Market: Competitive Structure
  • Table 7: Global: Continuous Glucose Monitoring Systems Market: Key Players
目次
Product Code: SR112023A5377

The global continuous glucose monitoring systems market size reached US$ 6.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.6 Billion by 2028, exhibiting a growth rate (CAGR) of 5.7% during 2023-2028.

Continuous glucose monitoring systems (CGMS) are technologically advanced devices that automatically track blood glucose levels. They consist of a transmitter-integrated sensor that functions through a transcutaneous or subcutaneous route to continuously measure the glucose concentration in interstitial fluid. The transmitter then sends the information to a wireless monitor that can be clipped to clothes. Continuous glucose monitoring systems assist in providing a complete profile of diabetes, alerting highs and lows of blood sugar levels, detecting patterns, and increasing patient insights regarding physical activity, medication choices, food portions and stress. As compared to conventional glucose monitoring devices, CGMS are prick-free as they can be placed over the skin, thus aiding in providing real-time information in a quick and painless fashion.

Continuous Glucose Monitoring Systems Market Trends:

The rising geriatric population across the globe that are more susceptible to developing diabetes is creating a positive outlook for the market. CGMS is commonly used for measuring glucose and insulin level in the body, which further sounds an alarm if it drops or rises to a dangerous level. In line with this, the widespread product utilization to identify hypoglycemia and hyperglycemic situations in real-time is favoring the market growth. Moreover, significant improvements and new technological advancements in CGMS that aid in detecting glycated hemoglobin (Hb1ac) in patients with diabetes are providing a considerable boost to the market growth. Additionally, the integration of artificial pancreas device systems with CGMS technology to pump insulin and administer optimum dosage to manage the blood sugar levels of patients is positively impacting the market growth. Apart from this, the introduction of non-invasive CGMS devices as a convenient alternative, extensive research and development (R&D) activities and the increasing demand for less or minimally invasive diagnostic tools are anticipated to drive the market further toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global continuous glucose monitoring systems market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, demographics and end user.

Breakup by Component:

Sensors

Transmitters and Receivers

Integrated Insulin Pumps

Breakup by Demographics:

Child Population (≤14 years)

Adult Population (>14 years)

Breakup by End User:

Clinics and Diagnostics Centers

ICUs

Home Healthcare

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being A. Menarini Diagnostics S.r.l., Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Glysens Incorporated, LifeScan Inc. (Johnson & Johnson), Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, Senseonics Holdings Inc. and Waveform Technologies Inc.

Key Questions Answered in This Report1. What was the size of the global continuous glucose monitoring systems market in 2022?

2. What is the expected growth rate of the global continuous glucose monitoring systems market during 2023-2028?

3. What has been the impact of COVID-19 on the global continuous glucose monitoring systems market?

4. What are the key factors driving the global continuous glucose monitoring systems market?

5. What is the breakup of the global continuous glucose monitoring systems market based on the component?

6. What is the breakup of the global continuous glucose monitoring systems market based on the demographics?

7. What is the breakup of the global continuous glucose monitoring systems market based on end user?

8. What are the key regions in the global continuous glucose monitoring systems market?

9. Who are the key players/companies in the global continuous glucose monitoring systems market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Continuous Glucose Monitoring Systems Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Component

  • 6.1  Sensors 
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Transmitters and Receivers 
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Integrated Insulin Pumps
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7   Market Breakup by Demographics

  • 7.1  Child Population (≤14 years)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Adult Population (>14 years)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8   Market Breakup by End User

  • 8.1  Clinics and Diagnostics Centers
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  ICUs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Home Healthcare
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10  SWOT Analysis

  • 10.1  Overview
  • 10.2  Strengths
  • 10.3  Weaknesses
  • 10.4  Opportunities
  • 10.5  Threats

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  A. Menarini Diagnostics S.r.l.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2  Abbott Laboratories
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3  DexCom Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4  F. Hoffmann-La Roche AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5  Glysens Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6  LifeScan Inc. (Johnson & Johnson)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7  Medtronic PLC
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8  Medtrum Technologies Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9  Nemaura Medical Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10  Novo Nordisk A/S
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11  Senseonics Holdings Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12  Waveform Technologies Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio